Startups
Acquisitions / Health / Software

DXC Technology is selling its healthcare software provider business for $525M

The Tysons, Virginia-based IT corporation's deal is expected to close by March 2021.

Doctors are going digital. (Public domain photo via National Institutes of Health)

Tysons, Virginia-based IT corporation DXC Technology has entered an agreement to sell its healthcare software provider business to Italy-based Dedalus Group for $525 million in cash.

Three-year-old DXC is an independent, end-to-end IT services and solutions company. Founded in 1982, Dedalus Group is a leading healthcare and diagnostic software provider in Europe. Four years ago, the company began focusing on making acquisitions as a larger expansion plan.

“The sale of our healthcare provider software business to Dedalus is consistent with our strategy of focusing on the Enterprise Technology Stack and rationalizing our portfolio,” said Mike Salvino, president and CEO of DXC Technology, in a statement. “The transaction promises to be beneficial to all our key stakeholders, including our customers and our people.”

DXC’s healthcare business provides medical professionals and caregivers with technology tools to improve their processes. Dedalus hopes to combine these tools with its already established healthcare and diagnostic software offerings to improve clinical IT areas of hospital information systems, according to a press release.

DXC’s board of directors has approved the transaction and the deal is expected to close by March 2021.

“The addition of DXC’s healthcare software business will accelerate our growth initiatives that started three years ago and benefit the more than 3 million healthcare professionals who use our technology to treat more than 200 million patients every year,” said Giorgio Moretti, executive chairman of the Dedalus Group.

The announcement of this deal comes a few months after DXC approved the sale of its U.S. state and local health and human services business for $5 million to Veritas Capital, an investor in government and healthcare technology businesses. This acquisition, expected to close by the year’s end, is a part of Salvino’s plan to divest three of the company’s businesses.

The company has a number of tech positions open at its Tysons HQ, including a DevOps engineer and a technician.

Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

How venture capital is changing, and why it matters

What company leaders need to know about the CTA and required reporting

Why the DOJ chose New Jersey for the Apple antitrust lawsuit

DC daily roundup: Meta's anti-trans hate problem; Key Bridge collapse's supply chain impact; OpGen has a new CEO

Technically Media